SumUp Chief Financial Officer Hermione McKee said the fresh capital gives the company “more firepower to act on opportunities,” including acquisitions and new country launches.
SumUp
British payments startup SumUp, known for its small card readers, on Monday announced it has raised 285 million euros ($306.6 million) in a bumper round of funding that values the company north of $8.6 billion.
Sixth Street Growth, the growth arm of global investment firm Sixth Street, led the investment in SumUp, while existing existing investor Bain Capital Tech Opportunities, fintech investment firm Fin Capital, and debt financing firm Liquidity Group, participated in SumUp’s latest round as well. The round predominantly consisted of equity, though a small portion of the funds was raised as debt.
SumUp Chief Financial Officer Hermione McKee said the fresh capital gives the company “more firepower to act on opportunities that we see arising over the course of the next two years.”
“If we think about our geographical expansion, in August we launched Australia as our 36th market globally,” McKee told CNBC in an interview last week ahead of the news.
“We have this foothold in Latin America and there’s more expansion that can be done there. Then we look at Asia, how do we think about that region, and then obviously opportunities across Africa. There’s so many opportunities globally. We’re constantly assessing this ‘buy versus build’ strategy.”
With this round, the company says it “continues to build further” on the valuation it attained in the summer of 2022, when SumUp was last valued at 8 billion euros ($8.6 billion) in a 2022 funding round that saw the firm raise a whopping 590 million euros of capital for growth and global expansion. A SumUp spokesperson confirmed the deal is an up round, meaning its valuation is higher than it was previously.
That’s no small achievement given the state of European technology valuations, which have taken a hammering over the past year as investors flee from tech due to higher interest rates and macroeconomic headwinds.
According to venture data firm PitchBook, median valuations declined in the third quarter across all stages compared to 2022, with late-stage valuations showing the most resilience and growth-stage the least.
Earlier this year, existing shareholders in SumUp sold stakes in the firm at a heavily discounted price to its last official valuation. One, online coupons site Groupon, disclosed in a filing with the U.S. Securities and Exchange Commission that it was selling off shares in SumUp at a price that would value the company at just 3.9 billion euros ($4.2 billion).
M&A shopping spree ahead
SumUp, which competes primarily with Jack Dorsey’s payments business Block, formerly known as Square, as well as PayPal’s iZettle, FIS’ WorldPay, Stripe, and Adyen, has been expanding into new lines of business lately, not least lending. The company launched a service that enables merchant to apply for a cash advance or business loans up to a certain limit based on their card sales revenues.
SumUp secured a $100 million credit facility from Victory Park Capital this summer to bolster its cash advance offering. McKee said that the lending product has been going well so far, with the vast majority of its merchants paying back in a timely manner.
“We’re seeing quick returns on that capital, and merchants that are genuinely supporting their growth. And then they’re able to repay that back in a short time periods for the transaction volume that we see,” McKee said.
“We haven’t seen any real pullback in terms of repayment data over the course of the last six months,” she added. “Our models are constantly iterating to make sure that that those factors we’re observing don’t become stale.”
SumUp also launched new point-of-sale offerings, including self-service kiosks that let customers order in stores using a touchscreen interface.
SumUp recently launched Apple’s Tap to Pay feature in the U.K. and the Netherlands, which enables people to tap their card or phone on a vendor’s iPhone using a smartphone app. It’s also been upgrading its existing point-of-sale systems, with its POS Lite and POS Pros countertop systems that can be paired with SumUp’s card readers.
Going forward, SumUp plans to explore more merger and acquisition opportunities to help it drive its expansion abroad.
“M&A is always something that’s on the table,” McKee said. “We have expanded into new geographies in the past with M&A. That’s something we’re always assessing. We have experience in both building an ecosystem as well as buying. And both of these things are available to us, obviously, yes, this just gives us greater optionality and the ability to move quickly, should we see the right opportunity arise.”
SumUp has no immediate plans to go public, McKee added, as it has ample access to capital in the private markets.
“I think it’s proven by this round that we actually have access to private pools of capital, so we don’t need to IPO,” she said.
“We’re constantly improving processes, actually making sure that we are operating at a standard and quality that is appropriate for public markets. But at the same time, this is not something that, you know, is imminent, and around the corner that we’re actively planning for today.”
Apple stock is getting its groove back as naysayers are proved wrong about the iPhone upgrade cycle. That means opportunity. Shares surged to an all-time intraday high Monday following a slew of positive commentary from Wall Street analysts and upbeat demand data for the newest iPhones. Apple was on pace to take out its Dec. 26, 2024 record-high close of $259. “People thought the tariffs were going to drive” iPhone prices higher, Jim Cramer during Monday’s Morning Meeting . “People [also] thought there was going to be not enough buying because of Siri. All nonsense.” “The misperception and misconception are overdone, and that’s why it’s a buy,” Jim added. New numbers from Counterpoint indicated the new iPhone 17 lineup has outsold the iPhone 16 models by 14% in the U.S. and China within its first 10 days of availability. Bloomberg first reported the data. “The base model iPhone 17 is very compelling to consumers, offering great value for money,” Counterpoint said. “A better chip, improved display, higher base storage, selfie camera upgrade – all for the same price as last year’s iPhone 16,” Counterpoint analysts added. “Buying this device is a no brainer, especially when you throw channel discounts and coupons into the mix.” For weeks now, Jim has been citing how the new iPhones are a bargain when considering the trade-in value of previous models and the carrier discounts. Counterpoint also said the brand new iPhone Air model has been doing “slightly better than the iPhone 16 Plus.” Preorders for the device in China began on Oct. 17. It sold out almost immediately. The analysts said, “This is a big milestone for Apple and more broadly for eSIM.” The iPhone Air is eSIM only, meaning it does not have the option for a physical SIM card. AAPL YTD mountain Apple (AAPL) year-to-date performance Wall Street analysts also enthusiastically chimed in. Loop Capital upgraded Apple to a buy from a hold. The analysts also hiked their price target to $315 per share from $226 — implying more than 19% upside from session highs of around $264. “While the Street is baking in some degree of outperformance from AAPL’s iPhone 17 family of products, we believe there remains material upside to Street expectations through CY2027,” according to Loop analysts. In this case, “through CY2027” means through calendar year 2027. That distinction is made because Apple’s fiscal year is such that when earnings are out after the bell on Oct. 30, they will be for the company’s fiscal 2025 fourth quarter. Over at Melius Research, analyst Ben Reitzes said Apple is “on a mission to silence its critics,” and that a beat and raise quarter “could be on the horizon.” “Near-term, sales into China are picking up and margins could deliver upside with iPhone 17 Pro Max momentum and lower hits from tariffs. We see shares getting a lift into CY26 and into a Siri/product event in the March 2026 timeframe,” said Reitzes, who has a buy rating and a $290 price target on the stock. “Apple’s Siri update has been delayed,” he said. “But it’s about to get better with significant AI enhancements.” None of this came to a surprise to Jim, who has been touting the benefits of Apple’s new iPhone models long before their September launch. “We’ve been saying the iPhone 17 is unbelievable,” he said on ” Squawk on the Street ” on Monday “Now, everybody’s catching up.” With Monday’s roughly 4.5% surge, shares of Apple were up almost 5.3% year to date. The stock for the first half of 2025 was a total dog on concerns around AI, various regulatory overhangs, and possible higher device costs from President Donald Trump ‘s tariffs. Since August, however, shares have been trending upwards following CEO Tim Cook’s additional $100 billion investment into U.S. manufacturing in order to appease the Trump administration’s call to bring Apple’s supply chain back home. “From the beginning, people underestimated it because they felt that Apple had lost its mojo,” Jim said. Monday’s spate of positive news just reiterates why shares have more room to run and why Jim always says own Apple stock, don’t trade it. To be sure, Apple shares were still underperforming most of its fellow “Magnificent seven” stocks, with the exception of Amazon , which has declined 2% year to date. (Jim Cramer’s Charitable Trust is long AAPL, AMZN. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Stocks are starting the week off on a positive note with every sector except consumer staples in the green. As stocks extend last week’s gains, Jim Cramer is closely watching the 10-year Treasury yield, which hovered at 4% Monday. He called the move “incredibly positive” because there are so many stocks that yield more than this. “It makes it so you want to buy stocks,” he added. Jim also reflected on his recent trip to San Francisco where he met with a range of CEOs to get fresh insights on artificial intelligence, the stock market and broader economic trends. He shared his top 10 takeaways from those meetings with Investing Club members in his Sunday column. 2. Boeing shares climbed more than 1% on Monday after the company officially got the green light late Friday to raise its monthly production of the 737 MAX to 42, up from 38. While reports last month hinted at the move, this marks official approval, paving the way for more monthly deliveries and stronger free cash flow. When Boeing reports earnings next week the one thing we’re looking out for is what the non-cash charge will be for the 777x program, the company’s next generation, long-haul jet designed to be the largest two-engine jet ever built. “This is a cashflow story and they have been losing money consistently for years now, and now it’s time to play offense,” Jim said. 3. “2026 is going to be a very good year” for Starbucks , said Jim, following his interview last week with CEO Brian Niccol on the company’s turnaround. Shares of the coffee giant were one of the big gainers in the market last week. The stock was up 8.7% after closing at a 52-week low on Oct. 10. Morgan Stanley is also feeling confident, increasing its price target on Starbucks stock to $105 from $103 Monday. Analysts said the upcoming quarter will likely show negative comps in its core North America business and is unlikely to mark a major step forward. But changes from the Green Apron service model (Starbucks’ new hospitality-focused initiative focused on enhancing the customer experience), restructuring, and new coffee products could set up a better 2026. Jim came away from the Niccol interview feeling optimistic about the company’s trajectory, especially hearing the value of the company’s China business is worth north of $10 billion , much higher than previously thought. “I think you buy the stock, and you buy it today,” Jim said. 4. Stocks covered in Monday’s rapid fire at the end of the video were: Skyworks Solutions , Marvell Technology , Darden Restaurants , Cleveland Cliffs , and Prologis . (Jim Cramer’s Charitable Trust is long BA, SBUX. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Dario Amodei, Anthropic CEO, speaking on CNBC’s Squawk Box outside the World Economic Forum in Davos, Switzerland on Jan. 21st, 2025.
Gerry Miller | CNBC
Anthropic on Monday announced Claude for Life Sciences, a new offering for researchers to use the company’s artificial intelligence technology in the advancement of scientific discovery.
Claude for Life Sciences is built around Anthropic’s existing AI models, but supports new connections with other scientific tools that are commonly used in labs during research and development.
It will be able to help researchers through all stages of the discovery process, from carrying out literature reviews to developing hypotheses, analyzing data, drafting regulatory submissions and more, Anthropic said.
The launch of Claude for Life Sciences marks Anthropic’s first formal entry into the sector, and comes just months after the company hired longtime industry executive Eric Kauderer-Abrams as its head of biology and life sciences.
“Now is the threshold moment for us where we’ve decided this is a big investment area,” Kauderer-Abrams told CNBC in an interview. “We want a meaningful percentage of all of the life science work in the world to run on Claude, in the same way that that happens today with coding.”
Read more CNBC tech news
Anthropic, which is one of the companies at the center of the AI boom, develops a family of large language models called Claude. It was founded in 2021 by a group of former OpenAI executives and researchers, and its valuation has swelled to $183 billion in just four years.
The company launched a new model, Claude Sonnet 4.5, late last month and said it is “significantly better” at life sciences tasks like understanding laboratory protocols.
Kauderer-Abrams said researchers have already been engaging with Anthropic’s models to help with isolated parts of the scientific process, so the company decided to formally build out Claude for Life Sciences as a way to support them from start to finish.
That meant Anthropic had to establish integrations with key players in the life sciences ecosystem, including Benchling, PubMed, 10x Genomics and Synapse.org, among others. Anthropic has also partnered with companies that can help life sciences organizations adopt AI, like Caylent, KPMG, Deloitte, and cloud providers AWS and Google Cloud, the company said.
“We’re willing and enthusiastic about doing that grind to make sure that all the pieces come together,” Kauderer-Abrams said.
In a prerecorded demo, Anthropic showed how a scientist working on preclinical studies could use Claude for Life Sciences to compare two study designs that test different dosing strategies.
The scientist was able to query her lab’s data directly from Benchling, generate a summary and tables of key differences with links back to the original material. After reviewing the results, the scientist generated a study report that could be included in a regulatory submission.
Anthropic said an analysis like this used to require “days” of validating and compiling information, but now, it can be done in minutes.
Kauderer-Abrams said the company believes AI can bring about real efficiency gains for the life sciences sector, but it’s also under “no illusions” that it will magically overcome the physical limitations of conducting scientific research. Clinical trials that take three years are not suddenly going to take one month, he said.
Instead, Anthropic is focused on exploring the time-consuming, expensive parts of the discovery process “piece by piece” to determine where AI could be most useful.
“We’re here to make sure that this transformation happens and that it’s done responsibly,” Kauderer-Abrams said.